Guardant Health, Inc. (GH)

101.85 +3.49 (+3.55%) USD  |  NASDAQ  |  Feb 06, 16:00
102.70 +0.85 (+0.83%) After-Hours: 20:00
More

Guardant Health Research and Development Expense (TTM) : 359.47M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Illumina, Inc. 950.00M
EXACT Sciences Corp. 429.14M
Natera, Inc. 578.38M
Quest Diagnostics, Inc. --
Labcorp Holdings, Inc. --